|
2022-09-06 |
2022-09-01 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
360
-0.4%
77.06
27,742
USD
|
360
-0.4%
|
77.06
|
27,742
USD
|
|
|
2022-09-06 |
2022-09-01 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
240
-0.3%
75.88
18,210
USD
|
240
-0.3%
|
75.88
|
18,210
USD
|
|
|
2022-09-06 |
2022-09-01 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
1,088
-1.2%
78.68
85,602
USD
|
1,088
-1.2%
|
78.68
|
85,602
USD
|
|
|
2022-09-06 |
2022-09-01 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
2,720
-2.9%
77.92
211,934
USD
|
2,720
-2.9%
|
77.92
|
211,934
USD
|
|
|
2022-09-06 |
2022-09-01 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
1,750
-1.8%
76.96
134,677
USD
|
1,750
-1.8%
|
76.96
|
134,677
USD
|
|
|
2022-09-06 |
2022-09-01 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
1,200
-1.3%
75.93
91,114
USD
|
1,200
-1.3%
|
75.93
|
91,114
USD
|
|
|
2022-09-06 |
2022-09-01 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
452
-0.5%
78.66
35,556
USD
|
452
-0.5%
|
78.66
|
35,556
USD
|
|
|
2022-09-06 |
2022-09-01 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
2,955
-3.0%
78.09
230,741
USD
|
2,955
-3.0%
|
78.09
|
230,741
USD
|
|
|
2022-09-06 |
2022-09-01 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
1,914
-1.9%
77.00
147,382
USD
|
1,914
-1.9%
|
77.00
|
147,382
USD
|
|
|
2022-09-06 |
2022-09-01 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
1,047
-1.0%
75.94
79,504
USD
|
1,047
-1.0%
|
75.94
|
79,504
USD
|
|
|
2022-08-04 |
2022-08-03 |
S
Sale
|
Benaim Ely
Chief Medical Officer
Officer
|
5,396
-15.8%
74.00
399,304
USD
|
5,396
-15.8%
|
74.00
|
399,304
USD
|
|
|
2022-08-04 |
2022-08-03 |
S
Sale
|
Benaim Ely
Chief Medical Officer
Officer
|
563
-1.6%
71.09
40,024
USD
|
563
-1.6%
|
71.09
|
40,024
USD
|
|
|
2022-08-03 |
2022-08-02 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
414
-0.4%
69.66
28,839
USD
|
414
-0.4%
|
69.66
|
28,839
USD
|
|
|
2022-08-03 |
2022-08-02 |
S
Sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
837
-0.2%
69.66
58,305
USD
|
837
-0.2%
|
69.66
|
58,305
USD
|
|
|
2022-08-03 |
2022-08-02 |
S
Sale
|
Benaim Ely
Chief Medical Officer
Officer
|
437
-1.2%
69.66
30,441
USD
|
437
-1.2%
|
69.66
|
30,441
USD
|
|
|
2022-06-16 |
2022-06-10 |
PS
Planned sale
|
HILLEMAN JERYL L
Non-Executive Director
|
407
-13.8%
69.61
28,331
USD
|
407
-13.8%
|
69.61
|
28,331
USD
|
|
|
2022-05-12 |
2022-05-11 |
S
Sale
|
Benaim Ely
Chief Medical Officer
Officer
|
2,135
-5.8%
61.25
130,769
USD
|
2,135
-5.8%
|
61.25
|
130,769
USD
|
|
|
2022-05-12 |
2022-05-10 |
S
Sale
|
Benaim Ely
Chief Medical Officer
Officer
|
2,070
-5.3%
65.16
134,877
USD
|
2,070
-5.3%
|
65.16
|
134,877
USD
|
|
|
2022-03-11 |
2022-03-09 |
S
Sale
|
Shah Pritesh
Chief Commercial Officer
Officer
|
3,669
-4.2%
71.19
261,196
USD
|
3,669
-4.2%
|
71.19
|
261,196
USD
|
|
|
2022-03-09 |
2022-03-08 |
S
Sale
|
Longsworth Todd Christopher
General Counsel
Officer
|
2,339
-3.6%
70.10
163,964
USD
|
2,339
-3.6%
|
70.10
|
163,964
USD
|
|
|
2022-03-09 |
2022-03-08 |
S
Sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
2,385
-0.4%
70.10
167,189
USD
|
2,385
-0.4%
|
70.10
|
167,189
USD
|
|
|
2022-03-09 |
2022-03-08 |
S
Sale
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Officer
|
2,923
-1.7%
70.10
204,902
USD
|
2,923
-1.7%
|
70.10
|
204,902
USD
|
|
|
2022-03-09 |
2022-03-08 |
S
Sale
|
Shah Pritesh
Chief Commercial Officer
Officer
|
2,481
-2.9%
70.10
173,918
USD
|
2,481
-2.9%
|
70.10
|
173,918
USD
|
|
|
2022-03-09 |
2022-03-08 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
759
-1.2%
70.10
53,206
USD
|
759
-1.2%
|
70.10
|
53,206
USD
|
|
|
2022-03-09 |
2022-03-08 |
S
Sale
|
Burke William Patrick
Chief Human Resources Officer
Officer
|
1,037
-1.8%
70.10
72,694
USD
|
1,037
-1.8%
|
70.10
|
72,694
USD
|
|
|
2022-03-09 |
2022-03-08 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
744
-0.7%
70.10
52,154
USD
|
744
-0.7%
|
70.10
|
52,154
USD
|
|
|
2022-03-09 |
2022-03-07 |
S
Sale
|
Shah Pritesh
Chief Commercial Officer
Officer
|
5,294
-5.9%
69.55
368,198
USD
|
5,294
-5.9%
|
69.55
|
368,198
USD
|
|
|
2022-03-07 |
2022-03-04 |
S
Sale
|
Benaim Ely
Chief Medical Officer
Officer
|
1,510
-3.4%
70.41
106,315
USD
|
1,510
-3.4%
|
70.41
|
106,315
USD
|
|
|
2022-03-07 |
2022-03-04 |
S
Sale
|
Burke William Patrick
Chief Human Resources Officer
Officer
|
1,026
-1.8%
70.41
72,238
USD
|
1,026
-1.8%
|
70.41
|
72,238
USD
|
|
|
2022-03-07 |
2022-03-04 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
556
-0.9%
70.41
39,146
USD
|
556
-0.9%
|
70.41
|
39,146
USD
|
|
|
2022-03-07 |
2022-03-04 |
S
Sale
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Officer
|
2,569
-1.5%
70.41
180,876
USD
|
2,569
-1.5%
|
70.41
|
180,876
USD
|
|
|
2022-03-07 |
2022-03-04 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
555
-0.5%
70.41
39,076
USD
|
555
-0.5%
|
70.41
|
39,076
USD
|
|
|
2022-03-07 |
2022-03-04 |
S
Sale
|
Shah Pritesh
Chief Commercial Officer
Officer
|
1,914
-2.1%
70.41
134,759
USD
|
1,914
-2.1%
|
70.41
|
134,759
USD
|
|
|
2022-03-07 |
2022-03-04 |
S
Sale
|
Shah Pritesh
Chief Commercial Officer
Officer
|
2,632
-2.8%
73.34
193,031
USD
|
2,632
-2.8%
|
73.34
|
193,031
USD
|
|
|
2022-03-07 |
2022-03-04 |
S
Sale
|
Longsworth Todd Christopher
General Counsel
Officer
|
1,973
-3.0%
70.41
138,913
USD
|
1,973
-3.0%
|
70.41
|
138,913
USD
|
|
|
2022-03-07 |
2022-03-03 |
S
Sale
|
Benaim Ely
Chief Medical Officer
Officer
|
803
-1.8%
74.50
59,822
USD
|
803
-1.8%
|
74.50
|
59,822
USD
|
|
|
2022-03-07 |
2022-03-03 |
S
Sale
|
Burke William Patrick
Chief Human Resources Officer
Officer
|
341
-0.6%
74.50
25,404
USD
|
341
-0.6%
|
74.50
|
25,404
USD
|
|
|
2022-03-07 |
2022-03-03 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
1,149
-1.8%
74.50
85,598
USD
|
1,149
-1.8%
|
74.50
|
85,598
USD
|
|
|
2022-03-07 |
2022-03-03 |
S
Sale
|
GROENHUYSEN WILHELMUS CM
Chief Operating Officer
Officer
|
1,301
-0.8%
74.50
96,922
USD
|
1,301
-0.8%
|
74.50
|
96,922
USD
|
|
|
2022-03-07 |
2022-03-03 |
S
Sale
|
Leonard Frank X
Chief Development Officer
Officer
|
930
-0.9%
74.50
69,283
USD
|
930
-0.9%
|
74.50
|
69,283
USD
|
|
|
2022-03-07 |
2022-03-03 |
S
Sale
|
Shah Pritesh
Chief Commercial Officer
Officer
|
997
-1.0%
74.50
74,275
USD
|
997
-1.0%
|
74.50
|
74,275
USD
|
|
|
2022-03-07 |
2022-03-03 |
S
Sale
|
Longsworth Todd Christopher
General Counsel
Officer
|
1,094
-1.6%
74.50
81,501
USD
|
1,094
-1.6%
|
74.50
|
81,501
USD
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Burke William Patrick
Chief Human Resources Officer
Officer
|
399
-0.8%
76.03
30,336
USD
|
399
-0.8%
|
76.03
|
30,336
USD
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Burke William Patrick
Chief Human Resources Officer
Officer
|
919
-1.8%
76.09
69,924
USD
|
919
-1.8%
|
76.09
|
69,924
USD
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Burke William Patrick
Chief Human Resources Officer
Officer
|
2,633
-6.0%
75.96
200,003
USD
|
2,633
-6.0%
|
75.96
|
200,003
USD
|
|
|
2021-11-29 |
2021-11-26 |
B
Purchase
|
Danziger Asaf
Chief Executive Officer
Executive Director
|
104
+0.8%
96.50
10,036
USD
|
104
+0.8%
|
96.50
|
10,036
USD
|
|
|
2021-11-29 |
2021-11-26 |
B
Purchase
|
Danziger Asaf
Chief Executive Officer
Executive Director
|
1,000
+8.2%
103.37
103,370
USD
|
1,000
+8.2%
|
103.37
|
103,370
USD
|
|
|
2021-11-29 |
2021-11-26 |
B
Purchase
|
Danziger Asaf
Chief Executive Officer
Executive Director
|
3,870
+46.6%
102.36
396,133
USD
|
3,870
+46.6%
|
102.36
|
396,133
USD
|
|
|
2021-11-03 |
2021-11-02 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
209
-0.5%
107.28
22,421
USD
|
209
-0.5%
|
107.28
|
22,421
USD
|
|
|
2021-08-16 |
2021-08-12 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
2,606
-5.4%
140.90
367,185
USD
|
2,606
-5.4%
|
140.90
|
367,185
USD
|
|
|
2021-08-16 |
2021-08-12 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
7,298
-13.7%
140.90
1,028,288
USD
|
7,298
-13.7%
|
140.90
|
1,028,288
USD
|
|
|
2021-08-16 |
2021-08-12 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
2,767
-5.7%
140.90
389,870
USD
|
2,767
-5.7%
|
140.90
|
389,870
USD
|
|
|
2021-08-16 |
2021-08-12 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
8,026
-14.9%
140.90
1,130,879
USD
|
8,026
-14.9%
|
140.90
|
1,130,879
USD
|
|
|
2021-08-16 |
2021-08-12 |
S
Sale
|
Cordova Ashley
Chief Financial Officer
Officer
|
5,927
-11.4%
141.06
836,063
USD
|
5,927
-11.4%
|
141.06
|
836,063
USD
|
|
|
2021-06-08 |
2021-06-07 |
PS
Planned sale
|
LEUNG GABRIEL
Non-Executive Director
|
1,000
-1.4%
204.55
204,550
USD
|
1,000
-1.4%
|
204.55
|
204,550
USD
|
|
|
2021-05-28 |
2021-05-27 |
S
Sale
|
Benaim Ely
Chief Medical Officer
Officer
|
1,833
-5.9%
200.00
366,600
USD
|
1,833
-5.9%
|
200.00
|
366,600
USD
|
|
|
2021-05-14 |
2021-05-12 |
S
Sale
|
Benaim Ely
Chief Medical Officer
Officer
|
1,943
-6.3%
180.48
350,673
USD
|
1,943
-6.3%
|
180.48
|
350,673
USD
|
|
|
2021-05-06 |
2021-05-05 |
PS
Planned sale
|
LEUNG GABRIEL
Non-Executive Director
|
1,000
-1.4%
199.67
199,670
USD
|
1,000
-1.4%
|
199.67
|
199,670
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
LEUNG GABRIEL
Non-Executive Director
|
2,500
-3.4%
200.00
500,000
USD
|
2,500
-3.4%
|
200.00
|
500,000
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
LEUNG GABRIEL
Non-Executive Director
|
3,500
-4.5%
198.01
693,035
USD
|
3,500
-4.5%
|
198.01
|
693,035
USD
|
|
|
2021-04-15 |
2021-04-13 |
S
Sale
|
Benaim Ely
Chief Medical Officer
Officer
|
3,474
-9.5%
200.00
694,800
USD
|
3,474
-9.5%
|
200.00
|
694,800
USD
|
|
|
2021-04-15 |
2021-04-13 |
S
Sale
|
Benaim Ely
Chief Medical Officer
Officer
|
651
-1.9%
200.00
130,200
USD
|
651
-1.9%
|
200.00
|
130,200
USD
|
|
|
2021-04-15 |
2021-04-13 |
S
Sale
|
Benaim Ely
Chief Medical Officer
Officer
|
1,833
-5.2%
200.00
366,600
USD
|
1,833
-5.2%
|
200.00
|
366,600
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
600
-0.1%
216.69
130,016
USD
|
600
-0.1%
|
216.69
|
130,016
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
500
-0.1%
214.67
107,333
USD
|
500
-0.1%
|
214.67
|
107,333
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
1,500
-0.3%
213.35
320,021
USD
|
1,500
-0.3%
|
213.35
|
320,021
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
600
-0.1%
211.28
126,766
USD
|
600
-0.1%
|
211.28
|
126,766
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
521
-0.1%
210.18
109,504
USD
|
521
-0.1%
|
210.18
|
109,504
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
2,200
-0.4%
209.34
460,555
USD
|
2,200
-0.4%
|
209.34
|
460,555
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
4,500
-0.8%
207.80
935,118
USD
|
4,500
-0.8%
|
207.80
|
935,118
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
1,284
-0.2%
206.35
264,956
USD
|
1,284
-0.2%
|
206.35
|
264,956
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
1,600
-0.3%
205.43
328,690
USD
|
1,600
-0.3%
|
205.43
|
328,690
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
1,972
-0.3%
204.28
402,834
USD
|
1,972
-0.3%
|
204.28
|
402,834
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
2,555
-0.4%
203.25
519,311
USD
|
2,555
-0.4%
|
203.25
|
519,311
USD
|
|
|
2021-04-15 |
2021-04-13 |
PS
Planned sale
|
DOYLE WILLIAM F
Executive Chairman
Executive Director
|
4,388
-0.8%
202.16
887,069
USD
|
4,388
-0.8%
|
202.16
|
887,069
USD
|
|
